ClinicalTrials.gov
ClinicalTrials.gov Menu

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00599287
Recruitment Status : Terminated (Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed consent.)
First Posted : January 23, 2008
Last Update Posted : March 21, 2018
Sponsor:
Information provided by:
UMC Utrecht

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 2008
  Actual Study Completion Date : May 2008